BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31292182)

  • 1. Validation of an algorithm using inpatient electronic health records to determine the presence and severity of cirrhosis in patients with hepatocellular carcinoma in England: an observational study.
    Driver RJ; Balachandrakumar V; Burton A; Shearer J; Downing A; Cross T; Morris E; Rowe IA
    BMJ Open; 2019 Jul; 9(7):e028571. PubMed ID: 31292182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, aetiology and related comorbidities of cirrhosis: a Swedish population-based cohort study.
    Vaz J; Eriksson B; Strömberg U; Buchebner D; Midlöv P
    BMC Gastroenterol; 2020 Apr; 20(1):84. PubMed ID: 32245414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis.
    Yang JD; Mohamed HA; Cvinar JL; Gores GJ; Roberts LR; Kim WR
    Am J Gastroenterol; 2016 Nov; 111(11):1573-1580. PubMed ID: 27527741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a coding algorithm to identify patients with hepatocellular carcinoma in an administrative database.
    Goldberg DS; Lewis JD; Halpern SD; Weiner MG; Lo Re V
    Pharmacoepidemiol Drug Saf; 2013 Jan; 22(1):103-7. PubMed ID: 23124932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ICD-10-AM codes for cirrhosis and related complications: key performance considerations for population and healthcare studies.
    Hayward KL; Johnson AL; Mckillen BJ; Burke NT; Bansal V; Horsfall LU; Hartel G; Moser C; Powell EE; Valery PC
    BMJ Open Gastroenterol; 2020 Sep; 7(1):. PubMed ID: 32943463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of HCC in Brazil: incidence and risk factors in a ten-year cohort.
    Paranaguá-Vezozzo DC; Ono SK; Alvarado-Mora MV; Farias AQ; Cunha-Silva M; França JI; Alves VA; Sherman M; Carrilho FJ
    Ann Hepatol; 2014; 13(4):386-93. PubMed ID: 24927609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of hepatocellular carcinoma in outpatients with cirrhosis in Brazil: A 10-year retrospective cohort study.
    Appel-da-Silva MC; Miozzo SA; Dossin IA; Tovo CV; Branco F; de Mattos AA
    World J Gastroenterol; 2016 Dec; 22(46):10219-10225. PubMed ID: 28028370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population-based study.
    Hong TP; Gow PJ; Fink M; Dev A; Roberts SK; Nicoll A; Lubel JS; Kronborg I; Arachchi N; Ryan M; Kemp WW; Knight V; Sundararajan V; Desmond P; Thompson AJ; Bell SJ
    Med J Aust; 2018 Oct; 209(8):348-354. PubMed ID: 30309301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine Learning-based Development and Validation of a Scoring System for Screening High-Risk Esophageal Varices.
    Dong TS; Kalani A; Aby ES; Le L; Luu K; Hauer M; Kamath R; Lindor KD; Tabibian JH
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1894-1901.e1. PubMed ID: 30708109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of a hierarchical algorithm to define chronic liver disease and cirrhosis etiology in administrative healthcare data.
    Philip G; Djerboua M; Carlone D; Flemming JA
    PLoS One; 2020; 15(2):e0229218. PubMed ID: 32069337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014.
    Kim D; Cholankeril G; Li AA; Kim W; Tighe SP; Hameed B; Kwo PY; Harrison SA; Younossi ZM; Ahmed A
    Liver Int; 2019 Sep; 39(9):1661-1671. PubMed ID: 31081997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and survival of hepatocellular carcinoma in the central region of Thailand.
    Somboon K; Siramolpiwat S; Vilaichone RK
    Asian Pac J Cancer Prev; 2014; 15(8):3567-70. PubMed ID: 24870758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.
    Su TH; Hu TH; Chen CY; Huang YH; Chuang WL; Lin CC; Wang CC; Su WW; Chen MY; Peng CY; Chien RN; Huang YW; Wang HY; Lin CL; Yang SS; Chen TM; Mo LR; Hsu SJ; Tseng KC; Hsieh TY; Suk FM; Hu CT; Bair MJ; Liang CC; Lei YC; Tseng TC; Chen CL; Kao JH;
    Liver Int; 2016 Dec; 36(12):1755-1764. PubMed ID: 27634134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver cirrhosis stages and the incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving antiviral therapy.
    Shim JJ; Oh CH; Kim JW; Lee CK; Kim BH
    Scand J Gastroenterol; 2017 Sep; 52(9):1029-1036. PubMed ID: 28562104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes Is Associated with Clinical Decompensation Events in Patients with Cirrhosis.
    Liu TL; Trogdon J; Weinberger M; Fried B; Barritt AS
    Dig Dis Sci; 2016 Nov; 61(11):3335-3345. PubMed ID: 27480088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study.
    Marcon PDS; Tovo CV; Kliemann DA; Fisch P; de Mattos AA
    World J Gastroenterol; 2018 Feb; 24(5):613-622. PubMed ID: 29434450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profile and value of FIB-4 in patients with dual chronic hepatitis C and B.
    Liu CJ; Tseng TC; Yang WT; Su TH; Yang HC; Liu CH; Chen PJ; Chen DS; Kao JH
    J Gastroenterol Hepatol; 2019 Feb; 34(2):410-417. PubMed ID: 30151861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of primary care electronic health record data of people living with hepatitis B virus: infection and hepatocellular carcinoma risk associated with socio-economic deprivation.
    Campbell C; Wang T; Gillespie I; Barnes E; Matthews PC
    Public Health; 2024 Jan; 226():215-227. PubMed ID: 38091810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis.
    N'Kontchou G; Paries J; Htar MT; Ganne-Carrie N; Costentin L; Grando-Lemaire V; Trinchet JC; Beaugrand M
    Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1062-8. PubMed ID: 16844421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease.
    Wong CR; Njei B; Nguyen MH; Nguyen A; Lim JK
    Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1061-1069. PubMed ID: 28960360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.